1140TiP Safe stop IPI-NIVO trial: Early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab
Janssen, J.C., van Dijk, B., de Joode, K., Aarts, M., Van den Berkmortel, F., Blank, C.U., Boers-Sonderen, M., Van Den Eertwegh, F., de Groot, J.W., Jalving, M., Joosse, A., Huismans, A., Kapiteijn, E., Naipal, K.A.T., Piersma, D., Rikhof, B., Vreugdenhil, G., Westgeest, H.M., Mulder, E.E.A.P., Van der Veldt, A.A.M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1092P Adjuvant treatment with anti-PD-1 in acral melanoma patients: A nationwide study
Bloem, M., van Not, O.J., Haanen, J.B.A.G., Blank, C.U., Aarts, M.J.B., Van den Berkmortel, F.W.P.J., de Groot, J.W., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R.S., Stevense-den Boer, M., Van der Veldt, A.A.M., Vreugdenhil, G., Bonenkamp, H., Boers-Sonderen, M.J., Blokx, W.A., Van Den Eertwegh, F., Suijkerbuijk, K.P.M., Wouters, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
859P The influence of hematologic malignancies on response to immune checkpoint inhibition in patients with advanced melanoma
van Not, O.J., Van Den Eertwegh, F., Haanen, J.B.A.G., van Rijn, R.S., Aarts, M., Van den Berkmortel, F., Blank, C.U., Boers-Sonderen, M., de Groot, J.W.B., Hospers, G., Kapiteijn, E., De Meza, M.M., Piersma, D., Stevense-den Boer, M., Van der Veldt, A.A.M., Vreugdenhil, G., Wouters, M., Blokx, W.A.M., Suijkerbuijk, K.P.M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
LBA43 Intradermal IMO-2125 versus placebo as adjuvant treatment in patients with stage II pT3-4/cN0 melanoma: Interim efficacy and safety results of the randomized phase II INTRIM study
Notohardjo, J.C.L., Veenstra, S., Koster, B.D., Kandiah, V., van der Velde, S., Francken, A.B., Gooiker, G.A., van den Tol, M.P., Bekkenk, M.W., Hof, K.H. in 't, Straver, M.E., Molenkamp, B.G., Vuylsteke, R.J.C.L.M., Lissenberg-Witte, B.I., Labots, M., Chunduru, S.K., van Akkooi, A.C.J., Van Den Eertwegh, F., de Gruijl, T.D.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
849P Time from primary melanoma to first distant recurrence in relation to survival outcomes in metastatic melanoma
van Duin, I.A.J., Elias, S.G., Van Den Eertwegh, F., de Groot, J.W.B., Blokx, W.A.M., van Not, O.J., Aarts, M., Blank, C.U., Haanen, J.B.A.G., Hospers, G., Piersma, D., van Rijn, R.S., Stevense-den Boer, M., Van der Veldt, A.A.M., Vreugdenhil, G., Wouters, M., Van den Berkmortel, F., Boers-Sonderen, M., Kapiteijn, E., Suijkerbuijk, K.P.M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1120P Post-approval trials versus patient registries: Comparability of advanced melanoma patients with brain metastases
Ismail, R., Sikkes, N., Wouters, M., Hilarius, D., Pasmooij, M., van den Eertwegh, F., Aarts, M., Van den Berkmortel, F., Boers-Sonderen, M., de Groot, J.W.B., Haanen, J.B.A.G., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R., Suijkerbuijk, K.P.M., Tije, A.J. ten, Van der Veldt, A.A.M., Vreugdenhil, G., van Dartel, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1103P Long-term survival of real-world advanced melanoma patients treated with targeted therapy
Ismail, R., de Boer, A., van Dartel, M., Hilarius, D., van Zeijl, M., van den Eertwegh, F., Aarts, M., Van den Berkmortel, F., Boers-Sonderen, M., de Groot, J.W.B., Haanen, J.B.A.G., Hospers, G.A.P., Kapiteijn, E., Piersma, D., van Rijn, R., Suijkerbuijk, K.P.M., Tije, A.J. ten, Van der Veldt, A.A.M., Vreugdenhil, G., Wouters, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
PCN344 - The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making
Franken, M, Leeneman, B, Schouwenburg, M, Jochems, A, Wouters, M, Van den Eertwegh, F, Haanen, J, Van der Hoeven, K, Uyl - de Groot, C
Published in Value in health (01.11.2015)
Published in Value in health (01.11.2015)
Get full text
Journal Article
The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making
Franken, M, Leeneman, B, Schouwenburg, M, Jochems, A, Wouters, M, Van den Eertwegh, F, Haanen, J, Van der Hoeven, K, Uyl - de Groot, C
Published in Value in health (01.11.2015)
Published in Value in health (01.11.2015)
Get full text
Journal Article
P072 - Enzalutamide with or without prior anti-androgen treatment for castration resistant prostate cancer (CRPC): Results from the Dutch CAPRI registry
Kuppen, M., Westgeest, H., Van Den Eertwegh, F., Van Moorselaar, J., Mehra, N., Coenen, J., Van Den Bergh, F., Aben, K., Bergman, A., Somford, D., Lavalaye, J., Uyl-De Groot, C., Gerritsen, W.
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Get full text
Journal Article
Post-docetaxel survival in metastatic castration-resistant prostate cancer (mCRPC) is improving in the Netherlands
Westgeest, H.-M., Kuppen, M., Van Den Eertwegh, F., Van Moorselaar, J., Mehra, N., Coenen, J., Van Oort, I., Van Den Bergh, F., Aben, K., Somford, R., Bergman, A., Lavalaye, J., Uyl-De Groot, C., Gerritsen, W.
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Get full text
Journal Article
P048 - Post-docetaxel survival in metastatic castration-resistant prostate cancer (mCRPC) is improving in the Netherlands
Westgeest, H.-M., Kuppen, M., Van Den Eertwegh, F., Van Moorselaar, J., Mehra, N., Coenen, J., Van Oort, I., Van Den Bergh, F., Aben, K., Somford, R., Bergman, A., Lavalaye, J., Uyl-De Groot, C., Gerritsen, W.
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Get full text
Journal Article
Enzalutamide with or without prior anti-androgen treatment for castration resistant prostate cancer (CRPC): Results from the Dutch CAPRI registry
Kuppen, M., Westgeest, H., Van Den Eertwegh, F., Van Moorselaar, J., Mehra, N., Coenen, J., Van Den Bergh, F., Aben, K., Bergman, A., Somford, D., Lavalaye, J., Uyl-De Groot, C., Gerritsen, W.
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.11.2018)
Get full text
Journal Article
610 - Outcomes of crossover between androgen receptor targeting drugs in the castration resistant prostate cancer registry (CAPRI)
Kuppen, M., Westgeest, H., Van Den Eertwegh, F., Van Moorselaar, J., De Wit, R., Van Oort, I., Aben, K., Verhoeven, R., Van Den Bergh, F., Coenen, J., Uyl-De Groot, C., Gerritsen, W.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Get full text
Journal Article
Outcomes of crossover between androgen receptor targeting drugs in the castration resistant prostate cancer registry (CAPRI)
Kuppen, M., Westgeest, H., Van Den Eertwegh, F., Van Moorselaar, J., De Wit, R., Van Oort, I., Aben, K., Verhoeven, R., Van Den Bergh, F., Coenen, J., Uyl-De Groot, C., Gerritsen, W.
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2018)
Get full text
Journal Article